Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Journal of Organic Chemistry
|
July 20, 2002
Catalytic oxidations of steroid substrates by artificial cytochrome p-450 enzymes
Jerry Yang, Bartolo Gabriele, Sandro Belvedere, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 2007
Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitors
Sandro Belvedere, David J Witter, Jiaming Yan, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 20, 2007
Benzo[b]thiophene-based histone deacetylase inhibitors
David J Witter, Sandro Belvedere, Liqiang Chen, et al.
Molecular Metabolism
|
February 12, 2021
FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice
Yun-Kyoung Lee, Bryan Diaz, Marianne Deroose, et al.
Molecular Metabolism
|
October 25, 2022
Single-agent FOXO1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice
Yun-Kyoung Lee, Wen Du, Yaohui Nie, et al.
Journal of Diabetes Investigation
|
March 1, 2024
Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells
Domenico Accili, Shivatra C Talchai, Ryotaro Bouchi, et al.
Molecular Metabolism
|
November 7, 2022
Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
Takumi Kitamoto, Yun-Kyoung Lee, Nishat Sultana, et al.
The Journal of Clinical Investigation
|
October 25, 2022
Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals
Wen Du, Junqiang Wang, Taiyi Kuo, et al.
The Journal of Clinical Investigation
|
October 25, 2022
A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas
Ja-Young Jang, Inah Hwang, Heng Pan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Journal of Organic Chemistry
|
July 20, 2002
Catalytic oxidations of steroid substrates by artificial cytochrome p-450 enzymes
Jerry Yang, Bartolo Gabriele, Sandro Belvedere, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 2007
Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitors
Sandro Belvedere, David J Witter, Jiaming Yan, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 20, 2007
Benzo[b]thiophene-based histone deacetylase inhibitors
David J Witter, Sandro Belvedere, Liqiang Chen, et al.
Molecular Metabolism
|
February 12, 2021
FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice
Yun-Kyoung Lee, Bryan Diaz, Marianne Deroose, et al.
Molecular Metabolism
|
October 25, 2022
Single-agent FOXO1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice
Yun-Kyoung Lee, Wen Du, Yaohui Nie, et al.
Journal of Diabetes Investigation
|
March 1, 2024
Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells
Domenico Accili, Shivatra C Talchai, Ryotaro Bouchi, et al.
Molecular Metabolism
|
November 7, 2022
Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
Takumi Kitamoto, Yun-Kyoung Lee, Nishat Sultana, et al.
The Journal of Clinical Investigation
|
October 25, 2022
Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals
Wen Du, Junqiang Wang, Taiyi Kuo, et al.
The Journal of Clinical Investigation
|
October 25, 2022
A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas
Ja-Young Jang, Inah Hwang, Heng Pan, et al.
Page
of 1